[Histamine release from human leukocytes by human recombinant interleukin-3]

Arerugi. 1990 May;39(5):452-8.
[Article in Japanese]

Abstract

Human recombinant interleukin-3 (hrIL-3) released histamine from human leukocytes in vitro. The histamine release by hrIL-3 significantly correlated with those by anti-IgE, thrombin, and f-met. peptide, but not by A23187. Histamine release by hrIL-3 was a Ca2(+)-dependent reaction, as was that by anti-IgE, although the time course of histamine release by hrIL-3 was slower than that by anti-IgE. Pre-treatment of leukocytes with hrIL-3 decreased the histamine release by hrIL-3 itself, but enhanced the histamine releases by anti-IgE, f-met. peptide, thrombin and A23187. These results suggested that the mechanism of hrIL-3-induced histamine release was different from those of anti-IgE, f-met. peptide, thrombin, and A23187. There was no significant difference between hrIL-3-induced histamine release of leukocytes from asthmatics and healthy controls.

Publication types

  • English Abstract

MeSH terms

  • Asthma / blood
  • Histamine Release / drug effects*
  • Humans
  • In Vitro Techniques
  • Interleukin-3 / pharmacology*
  • Leukocytes / drug effects*
  • Recombinant Proteins

Substances

  • Interleukin-3
  • Recombinant Proteins